These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20484589)

  • 1. Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification.
    Dopierala J; Damato BE; Lake SL; Taktak AF; Coupland SE
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4898-905. PubMed ID: 20484589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.
    Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex ligation-dependent probe amplification analysis of uveal melanoma with extraocular extension demonstrates heterogeneity of gross chromosomal abnormalities.
    Lake SL; Damato BE; Dopierala J; Baudo MM; Taktak AF; Coupland SE
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5559-64. PubMed ID: 21659309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma.
    Lake SL; Coupland SE; Taktak AF; Damato BE
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
    Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
    Parrella P; Caballero OL; Sidransky D; Merbs SL
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.
    van Gils W; Kilic E; Brüggenwirth HT; Vaarwater J; Verbiest MM; Beverloo B; van Til-Berg ME; Paridaens D; Luyten GP; de Klein A
    Melanoma Res; 2008 Feb; 18(1):10-5. PubMed ID: 18227702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
    Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A
    Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired homozygosity (isodisomy) of chromosome 3 during clonal evolution of a uveal melanoma: association with morphologic heterogeneity.
    White VA; McNeil BK; Thiberville L; Horsman DE
    Genes Chromosomes Cancer; 1996 Feb; 15(2):138-43. PubMed ID: 8834179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.
    Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A
    Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome profiling of melanocytic tumors using multiplex ligation-dependent probe amplification (MLPA): Its usefulness as an adjunctive diagnostic tool for melanocytic tumors.
    Takata M; Suzuki T; Ansai S; Kimura T; Shirasaki F; Hatta N; Saida T
    J Dermatol Sci; 2005 Oct; 40(1):51-7. PubMed ID: 16054806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death.
    Damato B; Dopierala J; Klaasen A; van Dijk M; Sibbring J; Coupland SE
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3048-55. PubMed ID: 19182252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
    Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
    Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
    Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transvitreal Retinochoroidal Biopsy Provides a Representative Sample From Choroidal Melanoma for Detection of Chromosome 3 Aberrations.
    Bagger M; Andersen MT; Heegaard S; Andersen MK; Kiilgaard JF
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5917-24. PubMed ID: 26377078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 3 intratumor heterogeneity in uveal melanoma.
    Mensink HW; Vaarwater J; Kiliç E; Naus NC; Mooy N; Luyten G; Brüggenwirth HT; Paridaens D; de Klein A
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):500-4. PubMed ID: 18824727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas.
    van Engen-van Grunsven AC; Baar MP; Pfundt R; Rijntjes J; Küsters-Vandevelde HV; Delbecq AL; Keunen JE; Klevering JB; Wesseling P; Blokx WA; Groenen PJ
    Melanoma Res; 2015 Jun; 25(3):200-9. PubMed ID: 25756553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and cytogenetic analyses in uveal melanoma.
    Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.